Laurie Keating, SVP, GC & Secretary at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 2,024 shares at $149.97 ($302K) on 2018-03-20, disclosed to the SEC on 2018-03-22.
Open-market sale of $302k ALNY by SVP, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $146.36 | 100 | $15K | 4.8% |
| 2 | $147.79 | 462 | $68K | 22.6% |
| 3 | $147.79 | 462 | $68K | 22.6% |
| 4 | $149.97 | 500 | $75K | 24.8% |
| 5 | $151.48 | 200 | $30K | 10.0% |
| 6 | $152.79 | 300 |
| $46K |
| 15.2% |
| Total | $149.36 avg | 2,024 | $302K | 100% |
| Filing → |
| ALNY | SELL | 2021-08-09 | $1.9M | — | Filing → |
| IMRX | BUY | 2021-08-04 | $105K | — | Filing → |
| ALNY | SELL | 2021-07-14 | $1.2M | — | Filing → |